United Therapeutics (UTHR) Other Working Capital Changes (2009 - 2014)
United Therapeutics (UTHR) reported Other Working Capital Changes of -$27.0 million for Q1 2026, up 79.93% on a YoY basis from -$15.0 million in Q1 2025, and down 127.49% sequentially from $98.2 million in Q4 2025.
United Therapeutics (UTHR) Other Working Capital Changes (2009 - 2014) Analysis & Trends
United Therapeutics (UTHR) has 13 years of Other Working Capital Changes data on file, last reported at -$27.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 79.93% year-over-year to -$27.0 million; the trailing twelve-month figure through Mar 2026 stood at $188.4 million (up 379.11% YoY), and the FY2025 full-year result was $80.9 million, up 1051.76% from the prior year.
- Other Working Capital Changes eased to -$27.0 million in Q1 2026, from $98.2 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $10.7 million in Q4 2014 to a low of -$5.0 million in Q3 2011.
- A 5-year average of $1.6 million and a median of $1.5 million in 2011 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes soared 648.41% in 2022 and tumbled 1086.05% in 2024, its largest moves.
- Tracing UTHR's Other Working Capital Changes over 5 years: stood at $94.3 million in 2022, then sank by 124.5% to -$23.1 million in 2023, then decreased by 16.88% to -$27.0 million in 2024, then surged by 463.7% to $98.2 million in 2025, then slumped by 127.49% to -$27.0 million in 2026.
- Business Quant data shows UTHR's Other Working Capital Changes at -$27.0 million in Q1 2026, $98.2 million in Q4 2025, and -$67.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 10.67 Mn |
| Dec 31, 2014 | 10.67 Mn |
| Dec 31, 2014 | 10.67 Mn |
| Sep 30, 2014 | -3.32 Mn |
| Sep 30, 2014 | -3.32 Mn |
| Sep 30, 2014 | -3.32 Mn |
| Jun 30, 2014 | -231,000.00 |
| Jun 30, 2014 | -231,000.00 |
| Jun 30, 2014 | -231,000.00 |
| Mar 31, 2014 | -500,000.00 |
| Mar 31, 2014 | -500,000.00 |
| Mar 31, 2014 | -500,000.00 |
| Dec 31, 2013 | 9.67 Mn |
| Dec 31, 2013 | 9.67 Mn |
| Dec 31, 2013 | 9.67 Mn |
| Sep 30, 2013 | -469,000.00 |
| Sep 30, 2013 | -469,000.00 |
| Sep 30, 2013 | -469,000.00 |
| Jun 30, 2013 | -923,000.00 |
| Jun 30, 2013 | -923,000.00 |